Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02280356 · ClinicalTrials.gov registry record · Phase 2
Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer
A Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
NCT02280356: Completed Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02280356 is a Phase 2 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02280356, a Phase 2 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to test the safety and side effects "of "ultra-hypofractionated" radiation therapy when used after brachytherapy (radiation implants). This treatment delivers a higher radiation dose with each treatment over a shorter period of time.
Interventions
- BEHAVIORAL questionnaires
- RADIATION brachytherapy
- RADIATION external beam radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2014-10-28 |
| Est. Completion | 2023-01-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02280356
The ClinicalTrials.gov registry entry for NCT02280356 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which questionnaires is the first listed.
NCT02280356 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02280356 about?
NCT02280356 is a clinical study titled "Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer". The purpose of this study is to test the safety and side effects "of "ultra-hypofractionated" radiation therapy when used after brachytherapy (radiation implants). This treatment delivers a higher radiation dose with each treatment over a shorter period of time.
What is the current status of trial NCT02280356?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2014-10-28. Estimated completion is 2023-01-09.
What interventions are being tested in trial NCT02280356?
The interventions under investigation include: questionnaires (BEHAVIORAL), brachytherapy (RADIATION), external beam radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT02280356?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.